143 related articles for article (PubMed ID: 1372368)
1. Cross-reactive and serotype-specific antibodies against foot-and-mouth disease virus generated by different regions of the same synthetic peptide.
Doel TR; Doel CM; Staple RF; DiMarchi R
J Virol; 1992 Apr; 66(4):2187-94. PubMed ID: 1372368
[TBL] [Abstract][Full Text] [Related]
2. Heterotypic protection induced by synthetic peptides corresponding to three serotypes of foot-and-mouth disease virus.
Doel TR; Gale C; Do Amaral CM; Mulcahy G; Dimarchi R
J Virol; 1990 May; 64(5):2260-4. PubMed ID: 2157884
[TBL] [Abstract][Full Text] [Related]
3. Protection conferred by TrpE fusion proteins containing portions of the C-terminal region of capsid protein VP1 of foot-and-mouth disease virus.
Giavedoni LD; Kaplan G; Marcovecchio F; Piccone ME; Palma EL
J Gen Virol; 1991 Apr; 72 ( Pt 4)():967-71. PubMed ID: 1849980
[TBL] [Abstract][Full Text] [Related]
4. Antibodies elicited by a biosynthetic peptide related to a major immunogenic area of FMDV A12.
Borca MV; Moore DM; Srikumaran S; Morgan DO
Viral Immunol; 1990; 3(2):147-60. PubMed ID: 1694429
[TBL] [Abstract][Full Text] [Related]
5. Delineation of a neutralizing subregion within the immunodominant epitope (GH loop) of foot-and-mouth disease virus VP1 which does not contain the RGD motif.
Brown F; Benkirane N; Limal D; Halimi H; Newman JF; Van Regenmortel MH; Briand JP; Muller S
Vaccine; 1999 Aug; 18(1-2):50-6. PubMed ID: 10501234
[TBL] [Abstract][Full Text] [Related]
6. Neutralizing antibodies to all seven serotypes of foot-and-mouth disease virus elicited by synthetic peptides.
Francis MJ; Hastings GZ; Clarke BE; Brown AL; Beddell CR; Rowlands DJ; Brown F
Immunology; 1990 Feb; 69(2):171-6. PubMed ID: 2155177
[TBL] [Abstract][Full Text] [Related]
7. Induction of anti foot and mouth disease virus T and B cell responses in cattle immunized with a peptide representing ten amino acids of VP1.
Zamorano PI; Wigdorovitz A; Pérez Filgueira DM; Escribano JM; Sadir AM; Borca MV
Vaccine; 1998 Apr; 16(6):558-63. PubMed ID: 9569465
[TBL] [Abstract][Full Text] [Related]
8. A protective anti-peptide antibody against the immunodominant site of the A24 Cruzeiro strain of foot-and-mouth disease virus and its reactivity with other subtype viruses containing the same minimum binding sequence.
Barnett PV; Pullen L; Staple RF; Lee LJ; Butcher R; Parkinson D; Doel TR
J Gen Virol; 1996 May; 77 ( Pt 5)():1011-8. PubMed ID: 8609466
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibodies to an Indian strain of type A foot-and-mouth disease virus.
Tosh C; Venkataramanan R; Pattnaik B; Hemadri D; Sanyal A
Acta Virol; 1999 Aug; 43(4):219-25. PubMed ID: 10749367
[TBL] [Abstract][Full Text] [Related]
10. Serological prospects for peptide vaccines against foot-and-mouth disease virus.
Parry NR; Ouldridge EJ; Barnett PV; Clarke BE; Francis MJ; Fox JD; Rowlands DJ; Brown F
J Gen Virol; 1989 Nov; 70 ( Pt 11)():2919-30. PubMed ID: 2479714
[TBL] [Abstract][Full Text] [Related]
11. A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants.
Taboga O; Tami C; Carrillo E; Núñez JI; Rodríguez A; Saíz JC; Blanco E; Valero ML; Roig X; Camarero JA; Andreu D; Mateu MG; Giralt E; Domingo E; Sobrino F; Palma EL
J Virol; 1997 Apr; 71(4):2606-14. PubMed ID: 9060612
[TBL] [Abstract][Full Text] [Related]
12. A single amino acid substitution affects multiple overlapping epitopes in the major antigenic site of foot-and-mouth disease virus of serotype C.
Mateu MG; Martínez MA; Capucci L; Andreu D; Giralt E; Sobrino F; Brocchi E; Domingo E
J Gen Virol; 1990 Mar; 71 ( Pt 3)():629-37. PubMed ID: 1690261
[TBL] [Abstract][Full Text] [Related]
13. A 10-amino-acid linear sequence of VP1 of foot and mouth disease virus containing B- and T-cell epitopes induces protection in mice.
Zamorano P; Wigdorovitz A; Perez-Filgueira M; Carrillo C; Escribano JM; Sadir AM; Borca MV
Virology; 1995 Oct; 212(2):614-21. PubMed ID: 7571431
[TBL] [Abstract][Full Text] [Related]
14. Mimicry of viral epitopes with retro-inverso peptides of increased stability.
Benkirane N; Guichard G; Briand JP; Muller S; Brown F; Van Regenmortel MH
Dev Biol Stand; 1996; 87():283-91. PubMed ID: 8854029
[TBL] [Abstract][Full Text] [Related]
15. Protective immune response to 16 kDa immunoreactive recombinant protein encoding the C-terminal VP1 portion of Foot and Mouth Disease Virus type Asia 1.
Bayry J; Prabhudas K; Gopalakrishna S; Patil PK; Ramakrishna C; Misra LD; Suryanarayana VV
Microbiol Immunol; 1999; 43(8):765-71. PubMed ID: 10524794
[TBL] [Abstract][Full Text] [Related]
16. New virus-specific T-helper epitopes of foot-and-mouth disease viral VP1 protein.
Volpina OM; Gelfanov VM; Yarov AV; Surovoy AYu ; Chepurkin AV; Ivanov VT
FEBS Lett; 1993 Oct; 333(1-2):175-8. PubMed ID: 7693508
[TBL] [Abstract][Full Text] [Related]
17. Distinct repertoire of antigenic variants of foot-and-mouth disease virus in the presence or absence of immune selection.
Borrego B; Novella IS; Giralt E; Andreu D; Domingo E
J Virol; 1993 Oct; 67(10):6071-9. PubMed ID: 7690417
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity of an aphthovirus chimera of the glycoprotein of vesicular stomatitis virus.
Grigera PR; Garcia-Briones M; Periolo O; la Torre JL; Wagner RR
J Virol; 1996 Dec; 70(12):8492-501. PubMed ID: 8970972
[TBL] [Abstract][Full Text] [Related]
19. Comparison between in vitro neutralization titres and in vivo protection against homologous and heterologous challenge induced by vaccines prepared from two serologically distinct variants of foot-and-mouth disease virus, serotype A22.
Bolwell C; Parry NR; Rowlands DJ
J Gen Virol; 1992 Mar; 73 ( Pt 3)():727-31. PubMed ID: 1312129
[TBL] [Abstract][Full Text] [Related]
20. Amino acid changes outside the G-H loop of capsid protein VP1 of type O foot-and-mouth disease virus confer resistance to neutralization by antipeptide G-H serum.
Krebs O; Ahl R; Straub OC; Marquardt O
Vaccine; 1993; 11(3):359-62. PubMed ID: 7680514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
